|
US5523226A
(en)
|
1993-05-14 |
1996-06-04 |
Biotechnology Research And Development Corp. |
Transgenic swine compositions and methods
|
|
US5670356A
(en)
|
1994-12-12 |
1997-09-23 |
Promega Corporation |
Modified luciferase
|
|
US5874304A
(en)
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
|
WO1999005266A2
(en)
|
1997-07-26 |
1999-02-04 |
Wisconsin Alumni Research Foundation |
Trans-species nuclear transfer
|
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
|
US20030104526A1
(en)
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US20050144655A1
(en)
|
2000-10-31 |
2005-06-30 |
Economides Aris N. |
Methods of modifying eukaryotic cells
|
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
WO2002046412A2
(en)
|
2000-12-07 |
2002-06-13 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
US7947469B2
(en)
|
2001-01-22 |
2011-05-24 |
Gendaq, Ltd. |
Modulation of HIV infection
|
|
US7273923B2
(en)
|
2001-01-22 |
2007-09-25 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
AUPR451401A0
(en)
|
2001-04-20 |
2001-05-24 |
Monash University |
A method of nuclear transfer
|
|
ATE347593T1
(de)
|
2002-01-23 |
2006-12-15 |
Univ Utah Res Found |
Zielgerichtete chromosomale mutagenese mit zinkfingernukleasen
|
|
US8206965B2
(en)
|
2002-03-15 |
2012-06-26 |
Cellectis S.A. |
Hybrid and single chain meganucleases and use thereof
|
|
EP1504092B2
(en)
|
2002-03-21 |
2014-06-25 |
Sangamo BioSciences, Inc. |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
|
US7612250B2
(en)
|
2002-07-29 |
2009-11-03 |
Trustees Of Tufts College |
Nuclear transfer embryo formation method
|
|
US9447434B2
(en)
|
2002-09-05 |
2016-09-20 |
California Institute Of Technology |
Use of chimeric nucleases to stimulate gene targeting
|
|
AU2003290518A1
(en)
|
2002-09-06 |
2004-04-23 |
Fred Hutchinson Cancer Research Center |
Methods and compositions concerning designed highly-specific nucleic acid binding proteins
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
|
EP1591521A1
(en)
|
2004-04-30 |
2005-11-02 |
Cellectis |
I-Dmo I derivatives with enhanced activity at 37 degrees C and use thereof
|
|
KR20070060115A
(ko)
|
2004-09-16 |
2007-06-12 |
상가모 바이오사이언스 인코포레이티드 |
단백질 생산을 위한 조성물 및 방법
|
|
EP1802193B1
(en)
|
2004-10-19 |
2014-04-30 |
Regeneron Pharmaceuticals, Inc. |
Method for generating a mouse homozygous for a genetic modification
|
|
WO2006097784A1
(en)
|
2005-03-15 |
2006-09-21 |
Cellectis |
I-crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
|
ATE466933T1
(de)
|
2005-03-15 |
2010-05-15 |
Cellectis |
I-crei-meganuklease-varianten mit modifizierter spezifität sowie verfahren zu ihrer herstellung und verwendung
|
|
CN101117633B
(zh)
|
2006-08-03 |
2011-07-20 |
上海交通大学附属儿童医院 |
一种细胞核移植方法
|
|
CA2669746C
(en)
|
2006-12-14 |
2017-05-16 |
Dow Agrosciences Llc |
Optimized non-canonical zinc finger proteins
|
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
|
EP3064599B1
(en)
|
2008-02-15 |
2018-12-12 |
Synthetic Genomics, Inc. |
Methods for in vitro joining and combinatorial assembly of nucleic acid molecules
|
|
KR20100120226A
(ko)
|
2008-04-11 |
2010-11-12 |
유티씨 파워 코포레이션 |
매니폴드 섬프를 갖는 바이폴라 플레이트 및 연료 전지
|
|
US8470594B2
(en)
|
2008-04-15 |
2013-06-25 |
President And Fellows Of Harvard College |
Methods for identifying agents that affect the survival of motor neurons
|
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
|
EP2206723A1
(en)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modular DNA-binding domains
|
|
CA2755192C
(en)
|
2009-03-20 |
2018-09-11 |
Sangamo Biosciences, Inc. |
Modification of cxcr4 using engineered zinc finger proteins
|
|
US8772008B2
(en)
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
|
US20120178647A1
(en)
|
2009-08-03 |
2012-07-12 |
The General Hospital Corporation |
Engineering of zinc finger arrays by context-dependent assembly
|
|
WO2011020014A1
(en)
|
2009-08-14 |
2011-02-17 |
Regeneron Pharmaceuticals, Inc. |
Promoter-regulated differentiation-dependent self-deleting cassette
|
|
KR20180036810A
(ko)
|
2009-08-14 |
2018-04-09 |
레비비코르 인코포레이션 |
당뇨병 치료를 위한 복수 형질전환 돼지
|
|
CN102666854B
(zh)
|
2009-10-29 |
2016-08-24 |
瑞泽恩制药公司 |
多功能等位基因
|
|
PT2816112T
(pt)
|
2009-12-10 |
2018-11-20 |
Univ Iowa State Res Found Inc |
Modificação do adn modificada pelo efector tal
|
|
WO2013030588A1
(en)
|
2011-08-31 |
2013-03-07 |
The University Of Manchester |
Method for diagnosing a neurodegenerative disease
|
|
WO2013041577A1
(en)
|
2011-09-20 |
2013-03-28 |
Vib Vzw |
Methods for the diagnosis of amyotrophic lateral sclerosis and frontotemporal lobar degeneration
|
|
WO2013141680A1
(en)
|
2012-03-20 |
2013-09-26 |
Vilnius University |
RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
|
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
|
ES2683071T3
(es)
|
2012-04-25 |
2018-09-24 |
Regeneron Pharmaceuticals, Inc. |
Direccionamiento mediado por nucleasas con grandes vectores de direccionamiento
|
|
ES2728782T3
(es)
|
2012-05-25 |
2019-10-28 |
Univ California |
Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
|
|
EP2690440A1
(en)
*
|
2012-07-25 |
2014-01-29 |
Institut du Cerveau et de la Moelle Épinière-ICM |
Protein level of C9ORF72 for diagnosing a neurodegenerative disease
|
|
WO2014033644A2
(en)
|
2012-08-28 |
2014-03-06 |
Novartis Ag |
Methods of nuclease-based genetic engineering
|
|
FI2906696T4
(fi)
|
2012-10-15 |
2023-03-18 |
|
Menetelmiä c9orf72:n ilmentymisen moduloimiseksi
|
|
EP2906697A4
(en)
|
2012-10-15 |
2016-06-22 |
Ionis Pharmaceuticals Inc |
METHOD FOR MONITORING THE C9ORF72 EXPRESSION
|
|
EP4397759A3
(en)
|
2012-10-23 |
2024-10-09 |
Toolgen Incorporated |
Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
|
|
DK3363902T3
(da)
|
2012-12-06 |
2020-01-02 |
Sigma Aldrich Co Llc |
Crispr-baseret genommodifikation og -regulering
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
SG10201707569YA
(en)
|
2012-12-12 |
2017-10-30 |
Broad Inst Inc |
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
|
|
IL308158A
(en)
|
2012-12-17 |
2023-12-01 |
Harvard College |
Rna-guided human genome engineering
|
|
MX2015010841A
(es)
|
2013-02-20 |
2016-05-09 |
Regeneron Pharma |
Modificacion genetica de ratas.
|
|
WO2014131833A1
(en)
|
2013-02-27 |
2014-09-04 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) |
Gene editing in the oocyte by cas9 nucleases
|
|
CN105408483A
(zh)
|
2013-03-15 |
2016-03-16 |
通用医疗公司 |
遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向
|
|
EP4286517A3
(en)
|
2013-04-04 |
2024-03-13 |
President and Fellows of Harvard College |
Therapeutic uses of genome editing with crispr/cas systems
|
|
DK3456831T3
(da)
|
2013-04-16 |
2021-09-06 |
Regeneron Pharma |
Målrettet modifikation af rottegenom
|
|
WO2015048577A2
(en)
|
2013-09-27 |
2015-04-02 |
Editas Medicine, Inc. |
Crispr-related methods and compositions
|
|
KR102251168B1
(ko)
|
2013-10-25 |
2021-05-13 |
셀렉티스 |
고 반복 모티프를 포함하는 dna 서열에 대한 효율적이고 특이적인 표적화를 위한 희소-절단 엔도뉴클레아제의 설계
|
|
MX388127B
(es)
|
2013-12-11 |
2025-03-19 |
Regeneron Pharma |
Metodos y composiciones para la modificacion dirigida de un genoma.
|
|
KR20160097338A
(ko)
|
2013-12-12 |
2016-08-17 |
더 브로드 인스티튜트, 인코퍼레이티드 |
뉴클레오티드 반복 장애에서의 crispr-cas 시스템의 조성물 및 방법 및 용도
|
|
JP6756700B2
(ja)
|
2014-03-18 |
2020-09-16 |
ユニバーシティ オブ マサチューセッツ |
筋萎縮性側索硬化症を処置するためのrAAVベースの組成物および方法
|
|
WO2015153760A2
(en)
|
2014-04-01 |
2015-10-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for prevention or treatment of a nervous system disorder
|
|
AU2015277369B2
(en)
|
2014-06-16 |
2021-08-19 |
The Johns Hopkins University |
Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter
|
|
US9738897B2
(en)
|
2014-06-23 |
2017-08-22 |
Regeneron Pharmaceuticals, Inc. |
Nuclease-mediated DNA assembly
|
|
WO2015200555A2
(en)
|
2014-06-25 |
2015-12-30 |
Caribou Biosciences, Inc. |
Rna modification to engineer cas9 activity
|
|
DK3161128T3
(en)
|
2014-06-26 |
2018-11-05 |
Regeneron Pharma |
METHODS AND COMPOSITIONS FOR TARGETED GENTICAL MODIFICATIONS AND PROCEDURES FOR USE THEREOF
|
|
CN106794141B
(zh)
|
2014-07-16 |
2021-05-28 |
诺华股份有限公司 |
将核酸包封在脂质纳米粒主体中的方法
|
|
WO2016024205A1
(en)
*
|
2014-08-15 |
2016-02-18 |
Pfizer Inc. |
Oligomers targeting hexanucleotide repeat expansion in human c9orf72 gene
|
|
EP3221457B1
(en)
|
2014-11-21 |
2019-03-20 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for targeted genetic modification using paired guide rnas
|
|
BR112017010490A2
(pt)
|
2014-12-05 |
2018-04-03 |
Regeneron Pharma |
roedor, polipeptídeo cd47, célula ou tecido de roedor isolado, célula-tronco emprionária de roedor, embrião de roedor, e, métodos de produzir um roedor, de fornecimento de um roedor, de enxerto de células humanas em um roedor, de avaliação de eficácia terapêutica de uma droga direcionada a células humanas e de avaliar as propriedades farmacocinéticas, de avaliar a toxicidade específica e inespecífica de uma droga direcionada ao cd47 humano.
|
|
MX388784B
(es)
|
2014-12-19 |
2025-03-20 |
Regeneron Pharma |
Métodos y composiciones para la modificación genética dirigida a través de direccionamiento múltiple de una sola etapa.
|
|
WO2016106236A1
(en)
|
2014-12-23 |
2016-06-30 |
The Broad Institute Inc. |
Rna-targeting system
|
|
US10793855B2
(en)
|
2015-01-06 |
2020-10-06 |
Ionis Pharmaceuticals, Inc. |
Compositions for modulating expression of C9ORF72 antisense transcript
|
|
US11104897B2
(en)
|
2015-04-27 |
2021-08-31 |
Genethon |
Compositions and methods for the treatment of nucleotide repeat expansion disorders
|
|
US20180344817A1
(en)
|
2015-05-01 |
2018-12-06 |
Precision Biosciences, Inc. |
Precise deletion of chromosomal sequences in vivo and treatment of nucleotide repeat expansion disorders using engineered nucleases
|
|
AU2016270587B2
(en)
|
2015-05-29 |
2020-12-24 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a disruption in a C9ORF72 locus
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
CA3035810A1
(en)
|
2015-09-02 |
2017-03-09 |
University Of Massachusetts |
Detection of gene loci with crispr arrayed repeats and/or polychromatic single guide ribonucleic acids
|
|
CA3009308A1
(en)
*
|
2015-12-23 |
2017-06-29 |
Chad Albert COWAN |
Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration
|
|
ES3030658T3
(en)
|
2016-03-30 |
2025-07-01 |
Intellia Therapeutics Inc |
Lipid nanoparticle formulations for crispr/cas components
|
|
WO2017178590A1
(en)
|
2016-04-14 |
2017-10-19 |
Université de Lausanne |
Treatment and/or prevention of dna-triplet repeat diseases or disorders
|
|
EP3488001A1
(en)
|
2016-07-25 |
2019-05-29 |
Mayo Foundation for Medical Education and Research |
Treating cancer
|
|
MX381216B
(es)
*
|
2016-09-30 |
2025-03-12 |
Regeneron Pharma |
Animales no humanos que tienen una expansion de repeticiones de hexanucleotidos en un locus c9orf72.
|
|
CN110337493B
(zh)
*
|
2016-10-28 |
2024-03-12 |
吉尼松公司 |
用于治疗肌强直性营养不良的组合物和方法
|
|
CN110234762A
(zh)
|
2016-10-28 |
2019-09-13 |
吉尼松公司 |
用于治疗肌强直性营养不良的组合物和方法
|
|
WO2018165541A1
(en)
|
2017-03-10 |
2018-09-13 |
The Board Of Regents Of The University Of Texas System |
Treatment of fuchs' endothelial corneal dystrophy
|
|
AU2018264996A1
(en)
|
2017-05-09 |
2019-12-05 |
University Of Massachusetts |
Methods of treating Amyotrophic Lateral Sclerosis (ALS)
|
|
EP3716767A4
(en)
|
2017-10-24 |
2021-11-24 |
Sangamo Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR TREATMENT OF RARE DISEASES
|
|
WO2020131632A1
(en)
|
2018-12-20 |
2020-06-25 |
Regeneron Pharmaceuticals, Inc. |
Nuclease-mediated repeat expansion
|
|
JP7618581B2
(ja)
|
2019-04-23 |
2025-01-21 |
サンガモ セラピューティクス, インコーポレイテッド |
9番染色体オープンリーディングフレーム72遺伝子発現のモジュレーターおよびその使用
|